molecularly-guided treatment of advanced nsclc: alk inhibitor sequencing
Published 5 years ago • 214 plays • Length 2:10Download video MP4
Download video MP3
Similar videos
-
1:42
next-generation alk inhibitors: treatment sequencing and resistance
-
3:34
alk-positive nsclc: the role of treatment selection and sequencing
-
6:27
alk inhibitor sequencing in nsclc
-
2:37
crown: lorlatinib in treatment-naïve patients with alk-positive advanced nsclc
-
2:07
clinical updates on alk inhibitor treatment strategies for nsclc
-
1:47
challenges in using alk inhibitors
-
1:14
treatment sequecing strategies in advanced nsclc
-
0:56
nautika1: safety and tolerability of neoadjuvant alectinib in alk-positive nsclc
-
22:10
first and second generation alk inhibitors for the treatment of lung cancer
-
7:11
targeted therapy for alk-positive nsclc: a practical case study | biomarker-guided therapy in nsc...
-
9:53
sequencing therapy in alk nsclc
-
1:24
choosing the best alk inhibitor for lung cancer
-
6:36
sequencing strategies for alk-targeted therapy
-
2:48
targeted therapy resistance mechanisms in alk nsclc
-
3:04
management of frontline alk nsclc: brigatinib vs. alectinib
-
1:05
dr. aggarwal on emerging treatment approaches in alk nsclc
-
7:03
sequencing therapies for alk-rearranged nsclc
-
26:57
segment 2: molecular targets in nsclc
-
0:58
progress in the treatment of alk-positive non-small cell lung cancer